Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 61 of 441 for:    colon cancer AND Capecitabine

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00531115
Recruitment Status : Terminated (According to the study design, in the first step the number of responses was lower than the number required (< 7).)
First Posted : September 18, 2007
Last Update Posted : February 20, 2013
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 2009
Actual Study Completion Date : April 2009